Advertisement

Topics

B. Riley & Co., LLC Company Profile

06:59 EDT 25th April 2018 | BioPortfolio

B. Riley & Co. is a leading independent investment bank which provides a full array of corporate finance, research, sales, trading and otcqx dad services to corporate, institutional and high net worth individual clients. Investment banking services include merger and acquisitions advisory to public and private middle market companies, initial and secondary public offerings and institutional private placements. Its Corporate Governance Advisory Services Group is engaged by both companies and investors to help maximize value for shareholders. The firm is recognized for its distinguished Equity Research. Founded in 1997, B. Riley is headquartered in Los Angeles and maintains offices in Newport Beach, San Francisco, and New York. It is a member of FINRA and SIPC. For more information, please visit www.brileyco.com.


News Articles [18 Associated News Articles listed on BioPortfolio]

B. Riley Weighs in on Fortress Biotech Inc's FY2017 Earnings

Fortress Biotech Inc - Research analysts at B. Riley issued their FY2017 earnings estimates for shares of Fortress Biotech in a research note issued to investors on Wednesday. B. Riley analyst M. Kuma...

Achillion Pharmaceuticals (ACHN) Research Coverage Started at B. Riley

The firm set a "neutral" rating and a $3.50 price target on the biopharmaceutical company's stock. B. Riley's price objective indicates a potential upside of 20.69% from the company's prev...

Seniorlink CEO Thomas Riley Recognized with 2018 What's Next Business Boomer Summit Leadership, ...

As one of five awards presented by the Boomer Summit, Riley was selected as an industry leader who disrupted the aging/senior living category by building Read more...

Prana Biotechnology (PRAN) PT Set at $4.00 by B. Riley

The brokerage presently has a "buy" rating on the biotechnology company's stock. B. Riley's target price would suggest a potential upside of 23.08% from the stock's current price.

Achillion Pharmaceuticals (ACHN) Coverage Initiated by Analysts at B. Riley

The firm set a "neutral" rating and a $3.50 price target on the biopharmaceutical company's stock. B. Riley's price target would indicate a potential upside of 19.86% from the stock's prev...

Walt Disney-Aktie: Vergnügungsparks machen die Musik!

Los Angeles - Walt Disney-Aktienanalyse von Analyst Barton Crockett von B. Riley FBR: Barton Crockett, Analyst beim Investmenthaus B. Riley FBR, bestätigt im Rahmen einer Aktienanalyse seine neutra.....

Tonix Pharmaceuticals to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), announced today that it will present at the B. Riley FBR Inaugural China Healthcare Investi...

Caladrius Biosciences to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

BASKING RIDGE, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multip...

Drugs and Medications [0 Results]

None

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Polyposis deserves a perfect physical examination for final diagnosis: Bannayan-Riley-Ruvalcaba syndrome.

Hızarcıoğlu-Gülşen H, Kılıç E, Dominguez-Garrido E, Aydemir Y, Utine GE, Saltık-Temizel İN. Polyposis deserves a perfect physical examination for final diagnosis: Bannayan-Riley-Ruvalcaba sy...

Reply to Dr Riley.

Aza-Riley Oxidation of Ugi-Azide and Ugi-3CR Products toward Vicinal Tricarbonyl Amides: Two-Step MCR-Oxidation Methodology Accessing Functionalized α,β-Diketoamides and α,β-Diketotetrazoles.

Direct oxidative deamination of glyoxal-derived Ugi-azide and Ugi three-component reaction products readily affords vicinal tricarbonyls (α,β-diketoamides) and α,β-diketotetrazoles with two divers...

An improved method for bivariate meta-analysis when within-study correlations are unknown.

Multivariate meta-analysis, which jointly analyzes multiple and possibly correlated outcomes in a single analysis, is becoming increasingly popular in recent years. An attractive feature of the multiv...

Reply to Collins and Riley.

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Carbidopa for the Treatment of Excessive Blood Pressure Variability

The overall study objectives are to determine whether carbidopa (Lodosyn®) is safe and well tolerated and to assess whether it can inhibit catecholamine-induced paroxysmal hypertension an...

Use of ACTIMMUNE in Patients With ADO2

This study is an open label use of ACTIMMUNE for patients with Autosomal Dominant Osteopetrosis Type 2(ADO2). Effects of treatment will be evaluated after 14 weeks on ACTIMMUNE by bone res...

Companies [3 Associated Companies listed on BioPortfolio]

B. Riley & Co., LLC

B. Riley & Co. is a leading independent investment bank which provides a full array of corporate finance, research, sales, trading and otcqx dad services to corporate, institution...

Riley Exploration Group, LLC

Healthcare Innovation Council

The Healthcare Innovation Council is an independent group of healthcare experts that generates and publicly shares innovative ideas about how U.S. hospitals and healthcare provide...

More Information about "B. Riley & Co., LLC" on BioPortfolio

We have published hundreds of B. Riley & Co., LLC news stories on BioPortfolio along with dozens of B. Riley & Co., LLC Clinical Trials and PubMed Articles about B. Riley & Co., LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of B. Riley & Co., LLC Companies in our database. You can also find out about relevant B. Riley & Co., LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record